To investigate the mechanism of protease-enhanced antibody activity to increase its therapeutic efficacy
碩士 === 國立中山大學 === 生物醫學研究所 === 102 === Monoclonal antibody has become clinical medicine of a variety of disease widely. According to the statistics of drug use, monoclonal antibody therapies apply to cancer, autoimmune diseases, inflammation and many infectious diseases, etc. And through the market s...
Main Authors: | Bo-cheng Huang, 黃柏誠 |
---|---|
Other Authors: | Tian-Lu Cheng |
Format: | Others |
Language: | zh-TW |
Published: |
2014
|
Online Access: | http://ndltd.ncl.edu.tw/handle/my7kbv |
Similar Items
-
Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood
by: Okazaki Akira, et al.
Published: (2009-02-01) -
Protease-Activation of Fc-Masked Therapeutic Antibodies to Alleviate Off-Tumor Cytotoxicity
by: Adrian Elter, et al.
Published: (2021-08-01) -
Antibody modulation: Limiting the efficacy of therapeutic antibodies
by: Vaughan, Andrew T., et al.
Published: (2015) -
Development of the protease-activated pro-antibody drug to enhance the specificity of disease target therapy
by: Yun-Chi Lu, et al.
Published: (2012) -
Questionable Efficacy of Therapeutic Antibodies in the Treatment of Anthrax
by: Jean-Nicolas Tournier, et al.
Published: (2019-06-01)